Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:11:12.432Z.
Consensus retrieved: 2026-10-06T09:36:07.983Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:11:12.432Z.
Quote observation: 2026-10-06T17:09:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16291309013886a388882617e5d80f34fb5e9972494eca64a5e5fc74bed8c75f
FORWARD PE RATIO
N/A
Benitec Biopharma Inc.
Market Cap
$301.04M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $301.04M | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.90M | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $293.47M | N/A |
| Standard BioTools Inc. (LAB)vs › | $288.35M | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $314.01M | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $287.53M | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $282.38M | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-06-30
Consensus estimates for this stock are reported in USD, while the share price trades in USD — so per-fiscal-year implied multiples can't be computed honestly here. The analyst estimates table shows the consensus figures with their correct currency label.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
